
Suz
@suz_stelloo
PhD training @zwartlab | genomics | prostate cancer | postdoc @LabVermeulen | proteomics | stem cells | enhancers | Veni laureate
ID: 956207262699225088
24-01-2018 16:49:11
722 Tweet
325 Takipçi
529 Takip Edilen



I’m excited to share our new study of the mechanisms of action of the therapeutic target ONECUT2 in prostate cancer. The protein activates a surprisingly wide range of resistance mechanisms. But we can suppress it with a drug! Prostate Cancer Foundation PCF Science doi.org/10.1093/nar/gk…

Science Magazine alphafold Pamela Ting Perspective: science.org/doi/10.1126/sc…




Third day of the #ISSCR2024. Visit today’s posters of my colleagues from RIMLS-Science radboud university. Poster #135 by Danique, poster #359 by Zicong Liu and poster #172 by Hendrik Marks



A first step towards a basis for research on #StemCell based #EmbryoModels rdcu.be/dSHtz Nature Cell Biology We hope that this will be useful in this new field where quality control and appropriate criteria are needed









Check out this latest pre-print by Christina Ramelow, MS, (she/her) from Srikant Rangaraju Steven Sloan labs , and co-authors Nick Seyfried biorxiv.org/content/10.110… Dreamt of native-state cell type-specific proteomics and transcriptomics? Introducing SPARO (Simultaneous Protein And RNA Omics).